DS-Connect®: The Down Syndrome Registry
2 other identifiers
observational
100,000
1 country
1
Brief Summary
The goal of this study is to develop a registry for Down syndrome (DS) to facilitate research participation by individuals with Down syndrome. DS-Connect® is an online survey tool designed to collect demographic data and health information from individuals with DS. It is open to all people with Down syndrome. The purposes of DS-Connect® are:
- 1.To identify the various phenotypic manifestations of DS.
- 2.To identify individuals with DS who may be eligible for research studies or new clinical trials, based on specific information about their diagnosis and health history.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 6, 2013
CompletedFirst Submitted
Initial submission to the registry
September 21, 2013
CompletedFirst Posted
Study publicly available on registry
September 25, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2035
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2035
January 31, 2025
January 1, 2025
21.7 years
September 21, 2013
January 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
To determine the prevalence of the various co-occurring conditions in Down syndrome.
Participants in DS-Connect® will complete health history surveys regarding medical diagnoses and can update the surveys annually or whenever their health changes.
Through study completion, up to 10 years
Facilitate participation in research for individuals with DS who may be eligible for research studies or new clinical trials.
Participants may choose to hear about Down syndrome research studies that may be relevant to their co-occurring conditions.
Through study completion, up to 10 years
Secondary Outcomes (1)
Enable aggregate data sharing from individuals with Down syndrome.
Through study completion, up to 10 years
Study Arms (1)
Down syndrome cohort
Individuals who have a diagnosis of complete trisomy 21, translocation Down syndrome or mosaic Down syndrome.
Eligibility Criteria
Individuals with DS (including those with mosaic DS and partial trisomy 21).
You may qualify if:
- Adults (at least 18 years of age) with a diagnosis of DS (including mosaic DS or partial trisomy 21) who are capable of providing consent to participate, or for whom a legally authorized representative (LAR) may give permission on behalf of the individual to participate. Adults with DS who cannot consent for themselves but can provide assent would need to provide assent to their LAR.
- Children (up to age 18 years of age) with a diagnosis of DS. Parents/guardians may enter registry information and give permission to participate on behalf of their child; if the child is over 7 years of age and able to provide assent, they must do so. (Note: Once a child has reached age 18, he or she will be prompted to re-enroll into the registry as an adult, if he/she is able to provide informed consent or with the consent of his/her LAR if unable to re-enroll themselves.)
- No individuals with DS will be excluded from taking part in DS-Connect based on age, race, ethnicity, or gender.
You may not qualify if:
- A person who does not have a diagnosis of DS (or mosaic DS or partial trisomy 21)
- Adults with DS who are not capable of providing informed consent or assent to participate and do not have a Legally Authorized Representative who can do so. In the case where an adults with DS is able to provide assent but does not do so, that adult will be excluded.
- A participant, parent, and/or LAR who cannot provide consent or does not read or understand a language that is available for the registry, either English or Spanish.
- A child with DS (between the ages of 7 and 18 years) who is capable of providing assent but does not do so.
- A child under the age of 18 years whose parents share joint custody and one parent indicates that they do not consent to the child's participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Linda Crnic Institute for Down Syndrome
Aurora, Colorado, 80045, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joaquin M Espinosa, Ph.D.
Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus
Central Study Contacts
Angela Rachubinski, PhD
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 21, 2013
First Posted
September 25, 2013
Study Start
September 6, 2013
Primary Completion (Estimated)
June 1, 2035
Study Completion (Estimated)
June 1, 2035
Last Updated
January 31, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
IPD will be available to other researchers through the INCLUDE Data Hub.